Kaufman Bros. Reinstates Taleo Corp (TLEO) at Hold; Most Comprehensive Talent Management Suite, But Wait for Sustainable Traction
Tweet
Share
E-mailGet Alerts TLEO Hot Sheet
Price: $45.98 --0%
Rating Summary:
2 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
2 Buy, 12 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Kaufman Bros. reinstates coverage on Taleo Corp (NASDAQ: TLEO) with a Hold. PT $37.
Kaufman analyst says, "We are encouraged by Taleo's initial success in growing non-recruiting business, as multi-product RFPs and cross-selling have led to billing growth recently. That said, we need to see sustainable traction in the non-recruiting areas before turning more positive on the stock, as the proportion of fast-growing areas such as performance management becomes larger in the business mix to drive overall growth."
For more ratings news on Taleo Corp click here and for the rating history of Taleo Corp click here.
Shares of Taleo Corp closed at $36.59 yesterday.
Kaufman analyst says, "We are encouraged by Taleo's initial success in growing non-recruiting business, as multi-product RFPs and cross-selling have led to billing growth recently. That said, we need to see sustainable traction in the non-recruiting areas before turning more positive on the stock, as the proportion of fast-growing areas such as performance management becomes larger in the business mix to drive overall growth."
For more ratings news on Taleo Corp click here and for the rating history of Taleo Corp click here.
Shares of Taleo Corp closed at $36.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- TD Cowen Assumes Iovanace Biotherapeutics (IOVA) at Buy
- TD Cowen Assumes Atara Biotherapeutics (ATRA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Kaufman Bros.Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
